BIBP 3226 inhibition of nicotinic receptor mediated chromaffin cell secretion

Peijin Zhang, Jialin Zheng, Terry D. Hexum

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


(R)-N2-(diphenacetyl)-N-[(4-hydroxyphenyl)methyl]-argininamide (BIBP 3226) is a selective neuropeptide Y Y1 receptor antagonist with structural similarity to the C-terminal tripeptide of neuropeptide Y. Based on this similarity we questioned whether BIBP 3226 could act as an agonist. Incubation of BIBP 3226 with bovine chromaffin cells in culture results in the inhibition of nicotinic receptor-stimulated catecholamine secretion (IC50=2.4 μM). The effect of BIBP 3226 is independent of neuropeptide Y action since the presence of neuropeptide Y in the culture medium does not alter the effect of BIBP 3226. BIBP 3226 decreased the efficacy of the nicotinic receptor agonist, 1,1-dimethyl-4-phenylpiperizinium (DMPP), but did not change its potency suggesting non-competitive inhibition. BIBP 3226 has a similar effect on nicotinic receptor-stimulated 45Ca2+ influx. BIBP 3226 does not inhibit [3H]norepinephrine release induced by high K+ and its effect is not pertussis toxin-sensitive. We conclude that not only can BIBP 3226 act as a neuropeptide Y receptor antagonist in bovine chromaffin cells but also act as an agonist and inhibit catecholamine secretion. Copyright (C) 1998 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)121-125
Number of pages5
JournalEuropean Journal of Pharmacology
Issue number2-3
StatePublished - Dec 4 1998


  • BIBP 3226
  • Catecholamine secretion
  • Chromaffin cell
  • Neuropeptide Y

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'BIBP 3226 inhibition of nicotinic receptor mediated chromaffin cell secretion'. Together they form a unique fingerprint.

Cite this